Healthcare provider profile · identity verified

Christopher Andrew Vasil, MD

Family Practice · WINSTON SALEM, NC · NPI 1689178600

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	627	172
Amlodipine Besylate	Amlodipine Besylate	466	132
Lisinopril	Lisinopril	437	126
Hydrochlorothiazide	Hydrochlorothiazide	368	112
Losartan Potassium	Losartan Potassium	334	97
Levothyroxine Sodium	Levothyroxine Sodium	309	78
Rosuvastatin Calcium	Rosuvastatin Calcium	259	86
Omeprazole	Omeprazole	253	63
Pravastatin Sodium	Pravastatin Sodium	221	60
Metoprolol Succinate	Metoprolol Succinate	189	58
Gabapentin	Gabapentin	188	56
Metformin Hcl Er	Metformin Hcl	178	52
Albuterol Sulfate Hfa	Albuterol Sulfate	168	55
Metformin Hcl	Metformin Hcl	165	44
Tamsulosin Hcl	Tamsulosin Hcl	157	45
Simvastatin	Simvastatin	156	45
Furosemide	Furosemide	155	46
Pantoprazole Sodium	Pantoprazole Sodium	142	39
Carvedilol	Carvedilol	127	38
Trazodone Hcl	Trazodone Hcl	106	26
Escitalopram Oxalate	Escitalopram Oxalate	105	33
Montelukast Sodium	Montelukast Sodium	104	27
Allopurinol	Allopurinol	95	27
Ezetimibe	Ezetimibe	95	27
Sertraline Hcl	Sertraline Hcl	93	25
Alprazolam	Alprazolam	86	17
Potassium Chloride	Potassium Chloride	79	23
Atenolol	Atenolol	74	20
Jardiance	Empagliflozin	73	16
Eliquis	Apixaban	71	17
Chlorthalidone	Chlorthalidone	70	20
Bupropion Xl	Bupropion Hcl	68	13
Prednisone	Prednisone	65	56
Meloxicam	Meloxicam	62	23
Citalopram Hbr	Citalopram Hydrobromide	60	17
Spironolactone	Spironolactone	57	14
Clopidogrel	Clopidogrel Bisulfate	56	15
Fluoxetine Hcl	Fluoxetine Hcl	53	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	13
Metoprolol Tartrate	Metoprolol Tartrate	51	19
Ozempic	Semaglutide	51	suppressed
Alendronate Sodium	Alendronate Sodium	50	15
Lorazepam	Lorazepam	50	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	15
Hydralazine Hcl	Hydralazine Hcl	47	13
Famotidine	Famotidine	46	16
Fluticasone Propionate	Fluticasone Propionate	45	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	37
Glimepiride	Glimepiride	43	12
Donepezil Hcl	Donepezil Hcl	39	suppressed
Baclofen	Baclofen	38	suppressed
Mirtazapine	Mirtazapine	36	12
Triamcinolone Acetonide	Triamcinolone Acetonide	35	16
Doxycycline Hyclate	Doxycycline Hyclate	34	30
Xarelto	Rivaroxaban	34	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Azithromycin	Azithromycin	31	30
Lovastatin	Lovastatin	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Finasteride	Finasteride	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	11
Diazepam	Diazepam	24	suppressed
Glipizide	Glipizide	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Estradiol	Estradiol	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	13
Pregabalin	Pregabalin	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	13
Memantine Hcl	Memantine Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Mometasone Furoate	Mometasone Furoate	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	11
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Amoxicillin	Amoxicillin	16	12
Cefdinir	Cefdinir	16	14
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Linzess	Linaclotide	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Digoxin	Digoxin	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Ramipril	Ramipril	12	suppressed
Torsemide	Torsemide	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error